BRILL TAKES TO TURF AS SHE GOES GATE TO WIRE TO WIN $75,000 LADY OF SHAMROCK STAKES BY 1 ¾ LENGTHS UNDER SMITH; TRAINED BY CHATLOS, SHE GETS MILE ON GRASS IN 1:35.75ARCADIA, Calif. (Dec. 28, 2019)–Idle since July 5, Brill made her first start on grass a winning one Saturday at Santa Anita, as she went to the lead out of the gate under Mike Smith and never looked back, winning the $75,000 Lady of Shamrock Stakes by 1 ¾ lengths. Trained by Don Chatlos, the 3-year-old daughter of Medaglia d’Oro got a flat mile over a turf course rated as “good” in 1:35.75.With Flavien Prat off of his opening day mounts due to illness, Hall of Fame veteran Mike Smith stepped into the void and despite the fact Brill was taking blinkers off today, she showed plenty of natural speed.“We felt she’d be on the lead,” said Chatlos. “She’s just a quick horse. She had been chasing some very fast fillies earlier this year at Oaklawn Park and it didn’t look like there was anything in here today of that caliber.“We put her on the grass because being by Medaglia d’Oro, we thought she’d like it and we think the grass will be better for her in the long run.”Fourth, beaten 18 lengths going 6 ½ furlongs in the Grade III Victory Ride Stakes at Belmont Park on July 5, Brill, who was purchased for $1 million as a Fasig Tipton July yearling by owner OXO Equine, LLC, was off at 7-2 in a field of eight 3-year-old fillies and paid $9.00, $4.80 and $3.00.“She had the blinkers off today, but she turned it on really nice and handled the grass really well,” said Smith. “I think that’s the kind of race they’ve been looking to see out of her. I believe she’s going to forward off of this.”Out of the Malibu Moon mare Hung the Moon, Brill, who was a close third three starts back in the Grade III Fantasy Stakes at Oaklawn on April 12, picked up her first stakes win in her eighth career start and with the winner’s share of $48,840 she increased her earnings to $231,040.Off as the 6-5 favorite, Keeper Ofthe Stars was attentive to the pace while saving ground throughout and proved second best, finishing 1 ¼ lengths in front of Lucky Peridot. Ridden by Abel Cedillo, Keeper Ofthe Stars paid $2.80 and $2.20.Off at 4-1 with Javier Castellano, Lucky Peridot prevailed by a nose over longshot Sold It and paid $2.80 to show.Fractions on the race were 23.06, 47.62, 1:12.38 and 1:24.15.
The leaked photo of Davero and Jaredo in a steamy kissA highly placed source at SOG records has confirmed to LIB Life that Jaredo and his former records labelmate Davero are in a love relationship.The pair are yet to officially announce their rumored relationship; however a leaked photo of them kissing in a lonely place and a number of public appearances by the two of them suggests the two are an item.The source added the two have been dating for more than a month now and things are actually moving on well between them by hanging out and getting to know one another.Emerging Liberian Afrobeats hit-maker, Jaredo.“Both artists are madly in love with each other and want to make the relationship serious,” the source said.Jaredo’s new love, Davero, who worked with the SOG record label for a while, is one of Liberia’s emerging female singers.As a highly successful star in her own right, Davero, 26, is currently one of the top grossing female artists in the country and has shared stages with top artists like Nigerian artists Davido, Kcee, Flavor and Tekno. She is also MTN LMA’s best female artist of the year (2018).When contacted, King Jaffar Jaredo, manager and owner of SOG records, did not deny or confirm the news about the relationship.Davero, 26, is currently one of the top grossing female artists in the country and has shared stages with top artists like Nigerian artists Davido, Kcee, Flavor and Tekno.King Jaffar added: “All I know is that the pair has been seeing each other lately and hanging together. I hope their closeness is about work but, if it is about a relationship, I will gladly accept it. Davero is a sweet and nice really nice girl.”Davero’s new lover, Jaredo, 18, is an upcoming Liberian music sensation who burst on the music scene with hits like “Wait for You” and “Nobody” — featuring Stunna and PCK respectively.The singer-songwriter who recently won the prestigious MTN Liberia Music Awards’ New Artists of the Year category in an interview with LIB Life last year said he became obsessed with music after listening to some of Wizkid’s songs.“I never thought of becoming a musician until I started listening to Wizkid’s songs, and his story inspired me to pursue a similar path. Although when I started singing, I was not too good, I worked hard to perfect my voice and to bring something new to the music industry.”Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)
For those with a hernia and thyroidA team of Spanish doctors, representing a charitable organization known as “Hernia International” in collaboration with the Esther and Jerelyn (E&J) Hospital in Ganta are carrying on free surgical operations in Ganta on people with a hernia and thyroid, which is commonly known as Gaitor.The team, comprising of seven surgical doctors from Spain arrived in the country on Saturday, January 26, and began operations on Sunday, January 27, where about 400 patients are expected to benefit.According to the Chief Medical Doctor of E&J Medical Center Dr. Peter George, the Spanish doctors are expected to conduct the free medical service for a week, beginning last Sunday.He said, upon their departure, another team of doctors from the USA will be coming into the country to assess the E&J facility, but could not reveal whether this US team will conduct surgery.When the Daily Observer visited the hospital’s compound, the Out-patients Department was overcrowded with a hernia and thyroid patients, while others were still coming to get registered for the operation.There are some Liberian doctors working alongside the visiting Spanish doctors for experience gaining or to get themselves acquainted, the Daily Observer was informed.Women with an umbilical hernia as well as children with a hernia were among the patients undergoing the free surgical operation.“We have about 600 patients registered to undergo this operation and more are still coming,” said one of the nurses, who is in charge of the registration.Since 2017, the E&J Hospital has been partnering with Hernia International for a free surgical operation on people with a hernia, but, looking at the increase in thyroid cases across Liberia, the organization deems it necessary to include “Thyroid” in the program, a representative said.Several countries, including Germany, USA, England, Slovenian have been sending doctors since the program began in 2017. There was happiness in the faces of those who successfully went under the operation.Dopoe Kpahn, a hernia patient said, “I am very happy because it took me 12 hours in bed after I underwent the operation.”However, Dr. George, who is also a member of Hernia International has assured of continuing the surgery along with his Liberian colleagues, upon the departure of the visiting doctors.Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)
Months later…accused rapist on station bailMore than two months have passed since a man allegedly sexually molested his nine-year-old female relative in the mining town of Linden, Region 10 (Upper Demerara-Berbice), and the alleged paedophile is yet to face the court.The male relative, who is in his 60s reportedly sexually molested the child twice during her weekend visit to her paternal relatives in the month of September.Police Commander of Region 10, Superintendent Hugh Winter, when contacted on Saturday, confirmed that the file in relation to this matter was dispatched to the office of the Director of Public Prosecutions (DPP) but that it has not been returned to him to date.However, he is hopeful that the advice on the way forward is communicated to the police soon.Reports are that the child left her residence on September 27 (Friday) to spend the weekend with relatives in the mining town and returned home on September 29 (Sunday) in a withdrawn state.The little girl then told her maternal aunt and other relatives about what transpired during her brief vacation with her relatives.“She said that she loves her aunty but that she cannot go back there [at their home]. She said that the uncle, her aunty’s husband, is a wicked man, she kept saying he is a wicked man when we asked her why she did not want to go back. Then she started telling us one by one what happened to her,” the grandmother had previously told this publication.The elderly woman had explained that the man took her granddaughter along with his two grandchildren to “Blue Water Lake” and a creek in “Buck Town” between Friday afternoon to Sunday afternoon under the pretence of teaching the young children to swim.However, he allegedly touched the child’s private parts inappropriately despite the child telling him to stop.
…urges visitors to avoid using minibuses…roads lack maintenance, Police sporadically enforce traffic lawsGuyana’s public infrastructure was put under a microscope in a United States (US) Department of State report, which states that road conditions in Guyana and consequential road safety, are sub-standard.According to the 2018 Crime and Safety Report on Guyana released a few days ago, roads are hardly maintained while street lighting is sporadic at best. It also notes that faced with sporadic enforcement of traffic laws from the Police, drivers often drive recklessly.According to the report, Police only enforce traffic laws ‘now and then’“Road conditions and road safety standards are below US standards. Roads are rarely maintained, and street lighting is sporadic. Vehicle accidents are very common, and accidents involving pedestrians are also very common. Traffic enforcement is rare to non-existent,” the report states.“Traffic accidents are a major concern in Georgetown, with speeding and driving under the influence of alcohol contributing factors. Road and driving conditions are poor. Police sporadically enforce local traffic laws, and local drivers often drive recklessly,” the report added.The report states that stop signs and traffic signals are often ignored by road users. The report urges drivers to be on the lookout for other cars and trucks, minibuses, horse-drawn carts, bicycles, scooters, motorcycles and pedestrians.It even urges drivers to beware of stray dogs, sleeping animals and free-range livestock, since all these things “share narrow, poorly maintained roads.” In addition, the report notes the lack of sidewalks.“A combination of very aggressive and inexperienced, timid vehicle operators makes driving especially dangerous. Speeding, reckless driving, tailgating, cutting across lanes and stopping quickly without signalling, passing at intersections, and passing on crowded streets are commonplace.”“Driving at night poses additional concerns due to poor street lighting and road conditions, drivers not lowering high beam lights, livestock, and pedestrians congregating by the roadside,” it states.VigilanceWhile the report does note that Guyana is a medium threat location for terrorism and political violence, it does warn US citizens to remain vigilant and always consider security issues when planning activities throughout Guyana.“Guyana does not have trained medical personnel who routinely respond to accidents, and ambulances generally do not have medical personnel or equipment on board to provide adequate medical care; ambulances are only for transportation. People injured in accidents are often transported by taxi,” the report also states.MinibusesThe report was particularly harsh on the use of public transportation in Guyana, specifically discouraging visitors from using minibuses. This would come even as members of the public have been increasingly critical of the unchecked rampage caused by most minibuses.This ranges from speeding and over packing these minibuses with passengers to loud and sometimes obscene music. Speeding minibuses have also been a common factor in most road accidents, especially those that end in fatalities.“The use of minibuses by visitors unfamiliar with the country is highly discouraged. The use of reputable taxis, (such as) those offered through the major hotels and tourist agencies, is preferable, as they are usually safer, more reliable, and affordable.”When it comes to visitors travelling into the Guyana’s hinterland, the report warns US citizens to only use well established tour companies in a bid to ensure their safety. Here, they pointed to reports of tourists being targeted.“Travel to the interior requires planning and caution. Medical and law enforcement resources in many interior locations are significantly less than what is available in the capital.”It noted that there have been reports of tourists and foreigners being robbed while travelling in the countryside, and there are occasional reports of bandits on rural roads and piracy on the local rivers.
Just three months ago, Amgen was still considered one of the biggest success stories of the fast-growing biotechnology industry. Now some analysts are comparing it to a lumbering, stumbling pharmaceutical giant that leans too heavily on an aging product portfolio. A series of setbacks, some unexpected and some perhaps self-inflicted, pose the greatest challenge in the company’s heretofore charmed 27-year history. And some crucial events in coming weeks could make clearer whether the company has simply hit a stretch of “choppy water” – as its chief executive contends – or whether, as some analysts say, the company’s best days may be behind it. “The barrage of bad news that’s come out on Amgen in the past 60 days is absolutely unprecedented in the biotech sector,” said Mark Schoenebaum, a biotechnology stock analyst at Bear Stearns. Amgen’s shares are down nearly 20 percent since late January, knocking about $20 billion off the company’s market value. But the stock has edged up a bit since its recent low of $55.13 on March 29, as some investors have apparently adopted management’s view that it is too soon for a fire sale. “We are not in a crisis, that’s for sure,” Kevin W. Sharer, Amgen’s chairman and chief executive, said in an interview. In a crisis, “people don’t know what to do,” he said. “People’s hair is on fire. Confidence is challenged. We’re not there.” Rather, he said, “we’re in some pretty choppy water.” The biggest waves are several recent studies suggesting that the company’s blockbuster anemia drugs, Aranesp and Epogen, might be harming patients, particularly if overused. Those products accounted for $6.6 billion of Amgen’s $14.3 billion in revenue last year. The Food and Drug Administration put new warnings on the drugs last month, citing studies suggesting that Aranesp and Epogen might cause heart problems or hasten the death of cancer patients. On Wednesday, the company said it would briefly delay the reporting of its first-quarter results, originally scheduled for next week, to allow it to include data from a clinical trial of Aranesp. The financial results are now expected April 23. Late Tuesday, Amgen said that its chief financial officer, Richard D. Nanula, was resigning to “pursue other opportunities,” but would stay on for three months to effect a transition. It also said that Robert Bradway would succeed him as the finance chief. Adding to its woes, Amgen recently reported that patients in a clinical trial combining its new colon cancer drug, Vectibix, with other treatments were more likely to die than patients who got only the other treatments. As a result, Vectibix is likely to remain only a niche drug for now. Sizing up Amgen’s situation in a report titled “Looking More Like Large Pharma,” a Citigroup analyst, Yaron Werber, has predicted that Amgen’s revenues will grow only 4 percent a year through 2010. That would be well below its 20 percent annual sales growth from 2003 to 2006. The company has mainly reacted to the mounting uncertainty about future sales by taking cost-control steps like a hiring slowdown and postponing the opening of a new factory in Ireland. If sales drop further, Amgen says, more cuts can be made. Results due in May Just how painful should become clearer in the next few weeks. By early May, the company is expected to release the results of a crucial study testing Aranesp’s effect on the longevity of patients with small-cell lung cancer. Aranesp is approved to treat the anemia caused by cancer chemotherapy. If the May results indicate that patients taking Aranesp are more likely to die sooner than they might otherwise, “the tide will turn” against the drugs, said Dr. John A. Glaspy, a professor of medicine at UCLA. “We will not be able to justify treating lots of patients” with Aranesp, said Glaspy, who has received consulting and research fees from Amgen. An FDA advisory committee plans to meet May 10 to discuss the safety of the anemia drugs. And later that month another big drugmaker, Roche, might win FDA approval for an anemia drug that would compete with Amgen’s products. Epogen and Aranesp are both genetically engineered versions of erythropoietin, or EPO, a protein made in the kidneys to stimulate production of oxygen-carrying red blood cells. Johnson & Johnson sells a version of Epogen, marketed as Procrit, under a license from Amgen. The drugs have been shown to reduce the need for blood transfusions in patients with kidney disease and in cancer patients getting chemotherapy. But in November, a study found that patients with kidney failure who were treated aggressively with an EPO drug had more deaths and heart problems than patients who took only enough of the drugs to raise their levels of red blood cells by more modest amounts. Then a number of studies came out suggesting that use of Aranesp by cancer patients could worsen their disease or hasten their deaths. Amgen did not immediately disclose the results of one of the trials, done by Danish researchers, prompting an inquiry by the Securities and Exchange Commission. Amgen executives, and some outside scientists, say it is still far from clear if the drugs are truly dangerous. Most of the studies showing risks have problems in their methodology or have not yet been published. The risks also seem to be mainly in patients whose red-cell counts are raised beyond the level recommended by the drugs’ labels. New products key Whatever happens with sales of its anemia drugs, if Amgen is to remain a fast-growing company it must develop new products. But it has yet to show a particular skill in that area, even though it does have many test drugs in its pipeline. To this day, Amgen still largely lives off Epogen, first approved in 1989, and Neupogen, a drug approved in 1991 that prevents infections in patients receiving chemotherapy. Its biggest new products since then, Aranesp and Neulasta, were modifications of the original two. And its other big product, the rheumatoid arthritis drug Enbrel, was not homegrown but came as part of the company’s $10 billion acquisition of Immunex in 2002. After being promoted to chief executive in 2000, Sharer recruited Roger M. Perlmutter from Merck to run research and development. The research effort has roughly tripled since 2002, to more than 6,000 people and $3.4 billion in spending, and the number of drug candidates under development has similarly soared. Denosumab, a drug for osteoporosis and bone cancer, could be a blockbuster, and some investors say that it is now more important than ever to Amgen’s future. But it will be two or three years before it is known whether the drug is safe and effective enough to win approval.160Want local news?Sign up for the Localist and stay informed Something went wrong. Please try again.subscribeCongratulations! You’re all set!
Blackburn have knocked back Hull’s £12million bid for Jordan Rhodes.Rovers manager Gary Bowyer acknowledged they had received an offer from the Tigers today, but it has now emerged the club have rejected it.The Championship outfit are believed to be demanding £15m for Rhodes, who cost them a club-record £8m when they signed the Scotland international from Huddersfield in August 2012.Rhodes, 24, has been in scintillating form since making the move to Ewood Park, scoring 53 goals in 99 games, and only recently signed a two-year contract extension with Blackburn.Hull are searching for a replacement for Shane Long, who they sold to Southampton for £12m last week, and it remains to be seen whether the Premier League side return with another bid. 1 Blackburn striker Jordan Rhodes
Spanish football expert Graham Hunter joined the Alan Brazil Sports Breakfast on Tuesday and discussed the likelihood of David Moyes returning to the Premier LeagueThe former Everton and Manchester United boss, in charge of Real Sociedad since November, is reportedly being targeted by West Ham to replace Sam Allardyce in the summer.But, according to Hunter, Moyes is ‘very happy’ in Spain, having led Sociedad away from relegation danger in La Liga, and it would take a big offer to prise him back to England.He said: “This has been a brilliant learning experience for him but he has taught more than he has learned.“He has taught that club about professionalism and he is in the process of sculpting that club and upgrading their practices to what is commonplace in the Premier League. He has enjoyed that very much.“I know, having spoken to him a lot recently, that he is a very happy man indeed.“With one year left on his contract, to say he wouldn’t come back to the Premier League is false. But it will take a very big offer from the right club to take him away.”
Anti-abortion hunger striker Tim Jackson is claiming a partial victory after the Taoiseach said he was willing to watch a video on an abortion.Senator Catherine Noone, chairwoman of the Oireachtas Committee on Abortion, wrote to Mr Jackson this morning on the fifth day of his protest.In correspondence, she said she has watched the video of an abortion and “the Taoiseach has no difficulty watching it.” The central demand of the hunger strike by the Ballybofey man is that the Taoiseach and the committee watch the video of an abortion before going any further with plans for a referendum on the 8th Amendment.Speaking this morning, Tim Jackson said he was pleased by the response.“Although the correspondence is a step in the right direction, I will keep going until the committee watch the video together in session. There is no other way of verifying if they all have watched it.”Jackson, who began on Monday, says his body is weakening but he remains determined that the committee are fully informed of what happens the baby in an abortion. “I think the least we all can do is know exactly how the child is killed, as it’s unmasks the reality of abortion in a debate clouded with euphemisms. It is a prerequisite for having a fully informed debate.”The video is available at whiteflagmovement.comHunger striker Jackson claims partial victory as Taoiseach said he is willing to watch video on abortion was last modified: September 23rd, 2017 by StephenShare this:Click to share on Facebook (Opens in new window)Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Reddit (Opens in new window)Click to share on Pocket (Opens in new window)Click to share on Telegram (Opens in new window)Click to share on WhatsApp (Opens in new window)Click to share on Skype (Opens in new window)Click to print (Opens in new window) Tags:abortiondailhunger strikeTim Jackson